Altered function of Parvalbumin expressing interneurons in mouse models of Huntington’s disease - Archive ouverte HAL Accéder directement au contenu
Communication Dans Un Congrès Année : 2016

Altered function of Parvalbumin expressing interneurons in mouse models of Huntington’s disease

Laurie Galvan
S. M. Holley
  • Fonction : Auteur
C. Cepeda
  • Fonction : Auteur
M. S. Levine
  • Fonction : Auteur

Résumé

Huntington's disease (HD), a neurodegenerative disorder caused by a mutation in the HD gene, is characterized by dysfunction and ultimate degeneration of striatal medium-sized spiny neurons (MSNs). Although it was thought that interneurons were relatively spared in HD, recent studies have shown signi cant alterations in parvalbumin (PV)-expressing interneurons. These interneurons display fast-ring properties and mediate feed-forward inhibition in the striatum. Previously we showed using optogenetics to speci cally activate PV-expressing interneurons that alterations in GABAergic input from PV-expressing interneurons may contribute to MSN dysfunction in HD. Here we used a similar optogenetic paradigm to further examine alterations in PV-expressing interneuron inputs to MSNs in the R6/2 and the Q175 models. We examined whether PV-expressing interneuron responses in R6/2 mice were di erentially a ected in direct versus indirect pathway MSNs. R6/2 mice were crossed with PV-Cre mice and D1 tomato mice to identify direct and indirect pathway MSNs. The data show that PV-expressing interneurons induced a larger GABAergic response in direct compared to indirect pathway wildtype (WT) MSNs. In symptomatic R6/2 mice, direct pathway MSNs displayed a smaller response compared to the WT direct pathway response. Q175 mice were crossed with PV-Cre mice to examine the progression of response alterations in MSNs at 2 (presymptomatic) and 8 (beginning of symptomatic stage) months. In 2 month Q175 mice, there were no di erences between genotypes. In contrast, in 8 month Q175 mice, activation of striatal PV-expressing interneurons evoked signi cantly smaller MSN GABAergic responses with a faster decay time than in WTs. We also compared the e ects of activation of endocannabinoid receptor 1 (CB1) in the two models. The CB1 agonist, WIN 55,212-2 decreased PV-induced responses in both Q175 and WT MSNs but not in the symptomatic R6/2 MSNs as previously described. Together, these ndings suggest that alterations in function of PV-expressing interneurons di er in the R6/2 and Q175 mice but will contribute to neuronal microcircuit alterations in the striatum.
Fichier non déposé

Dates et versions

hal-02534713 , version 1 (23-02-2021)

Identifiants

  • HAL Id : hal-02534713 , version 1

Citer

Laurie Galvan, S. M. Holley, C. Cepeda, M. S. Levine. Altered function of Parvalbumin expressing interneurons in mouse models of Huntington’s disease. SFN 2016, Nov 2016, SAN DIEGO, United States. ⟨hal-02534713⟩
40 Consultations
1 Téléchargements

Partager

Gmail Facebook X LinkedIn More